Alice Bexon is V.P. Clinical Development at IDERA PHARMACEUTICALS, INC. (IDRA). They have made 1 open-market trade across 1 company since 2008, most recently 2008-03-14.
CIK 0001404061
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDRA | 27,499 | $199K |
Shares reported on the most recent Form 4, priced at the 2008-03-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDRA | SELL | 2008-03-14 | 2008-03-17 | $9.48 | $261K | -30.0% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.